Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial.

Mashayekhi M, Beckman JA, Nian H, Garner EM, Mayfield D, Devin JK, Koethe JR, Brown JD, Cahill KN, Yu C, Silver H, Niswender K, Luther JM, Brown NJ

Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.

Ackroyd SA, Arguello D, Ramos P, Mahdi H, ElNaggar A, Winer I, Holloway R, Krivak T, Jones N, Turner VG, Herzog T, Chu C, Brown J, Mantia-Smaldone G

Case series profile of olanzapine post-injection delirium/sedation syndrome.

Seebaluck J, Downes MA, Brown J, Harris K, Isoardi KZ, Chan BS

Development of the Patient Scale of the Patient and Observer Scar Assessment Scale (POSAS) 3.0: a qualitative study.

Carrière ME, Mokkink LB, Tyack Z, Westerman MJ, Pijpe A, Pleat J, van de Kar AL, Brown J, de Vet HCW, van Zuijlen PPM

Anthropomorphic model rigid loading indenter with embedded sensor development for wheelchair cushion standard testing.

Chung CS, Grindle GG, Brown JD, Gebrosky B, Carrigan W, Nuthi P, Wijesundara MBJ, Cooper RA

Evaluation and updates to the Leggett model for pharmacokinetic modeling of exposure to lead in the workplace - Part II adjustments to the adult exposure model, confirmation of Leggett+, and modeling of workplace exposure.

Vork KL, Brown JP, Carlisle JC

Methylarginine efflux in nutrient-deprived yeast mitigates disruption of nitric oxide synthesis.

Brown JI, Alibhai J, Zhu E, Frankel A

Falls from ladders in New South Wales: A data-linkage study.

Hamdard K, Harris IA, Sarrami P, Shu CC, Brown J, Singh H, Levesque JF, Dinh M

Neuronal deletion of MnSOD in mice leads to demyelination, inflammation and progressive paralysis that mimics phenotypes associated with progressive multiple sclerosis.

Bhaskaran S, Kumar G, Thadathil N, Piekarz KM, Mohammed S, Lopez SD, Qaisar R, Walton D, Brown JL, Murphy A, Smith N, Saunders D, Beckstead MJ, Plafker S, Lewis TL Jr, Towner R, Deepa SS, Richardson A, Axtell RC, Van Remmen H

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.

Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N, CLARITY study investigators